Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
15.28
+0.19 (1.26%)
Feb 3, 2026, 3:04 PM CST
SHE:300705 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 543.74 | 443.31 | 425.05 | 345.84 | 398.41 | 135.26 |
Trading Asset Securities | 130.73 | 260.71 | 90.29 | 90.26 | 100.31 | - |
Cash & Short-Term Investments | 674.47 | 704.02 | 515.34 | 436.1 | 498.72 | 135.26 |
Cash Growth | -5.01% | 36.61% | 18.17% | -12.56% | 268.72% | 2.80% |
Accounts Receivable | 435.27 | 469.33 | 625.76 | 503.58 | 284.9 | 189.5 |
Other Receivables | 5.97 | 7.46 | 3.72 | 0.49 | 2.15 | 1.03 |
Receivables | 441.24 | 476.8 | 629.48 | 504.07 | 287.05 | 190.52 |
Inventory | 396.2 | 367.7 | 265.53 | 241.04 | 214.48 | 153.12 |
Other Current Assets | 67.28 | 53.26 | 19.61 | 25.28 | 20.03 | 24.71 |
Total Current Assets | 1,579 | 1,602 | 1,430 | 1,206 | 1,020 | 503.6 |
Property, Plant & Equipment | 1,460 | 1,355 | 1,141 | 892.29 | 606.83 | 533.15 |
Long-Term Investments | 194.7 | 122.29 | 30 | 30 | - | - |
Other Intangible Assets | 128.84 | 111.58 | 88.82 | 91.66 | 77.36 | 51.06 |
Long-Term Deferred Tax Assets | 43.63 | 49.52 | 66.29 | 43.25 | 29.19 | 17.85 |
Long-Term Deferred Charges | 64.24 | 42.69 | 27.69 | 10.73 | 3.16 | 2.77 |
Other Long-Term Assets | 200.72 | 90.63 | 87.47 | 25.29 | 8.43 | 22.29 |
Total Assets | 3,671 | 3,373 | 2,871 | 2,300 | 1,745 | 1,131 |
Accounts Payable | 111.28 | 150.72 | 159.29 | 143.8 | 108.88 | 59.91 |
Accrued Expenses | 36.29 | 93.25 | 80.59 | 85.84 | 47.27 | 36.04 |
Short-Term Debt | - | - | 51.85 | 71.57 | 53.77 | 10.4 |
Current Portion of Long-Term Debt | 35.45 | 8.89 | 5.95 | 13.12 | 50.54 | 7.52 |
Current Portion of Leases | - | 0.05 | 0.11 | 0.11 | - | - |
Current Income Taxes Payable | 37.67 | 3.22 | 8.92 | 0.69 | 7.73 | 2.74 |
Current Unearned Revenue | 27.6 | 30.42 | 37.27 | 72.25 | 57.41 | 42.16 |
Other Current Liabilities | 80.35 | 105.31 | 71.58 | 56.97 | 44.79 | 22.2 |
Total Current Liabilities | 328.64 | 391.86 | 415.56 | 444.34 | 370.38 | 180.96 |
Long-Term Debt | 454.84 | 293.77 | 332.48 | 231.49 | 224.28 | 70.5 |
Long-Term Leases | - | - | 0.05 | 0.15 | - | - |
Long-Term Unearned Revenue | 179.29 | 155.95 | 145.37 | 65.52 | 51.25 | 43.58 |
Long-Term Deferred Tax Liabilities | 13.13 | 4.82 | 4.47 | 5.59 | - | - |
Total Liabilities | 975.9 | 846.4 | 897.93 | 747.09 | 645.9 | 295.04 |
Common Stock | 500.21 | 496.19 | 345.15 | 342.94 | 234.69 | 234.68 |
Additional Paid-In Capital | 563.97 | - | - | 484.87 | 278.97 | 278.79 |
Retained Earnings | 1,666 | 1,414 | 1,012 | 724.82 | 516.37 | 322.22 |
Comprehensive Income & Other | 44.62 | 616.9 | 615.98 | - | 69.31 | - |
Shareholders' Equity | 2,695 | 2,527 | 1,973 | 1,553 | 1,099 | 835.68 |
Total Liabilities & Equity | 3,671 | 3,373 | 2,871 | 2,300 | 1,745 | 1,131 |
Total Debt | 490.3 | 302.71 | 390.44 | 316.44 | 328.58 | 88.42 |
Net Cash (Debt) | 184.17 | 401.31 | 124.9 | 119.66 | 170.14 | 46.83 |
Net Cash Growth | -46.26% | 221.30% | 4.38% | -29.67% | 263.28% | - |
Net Cash Per Share | 0.36 | 0.81 | 0.25 | 0.26 | 0.37 | 0.10 |
Filing Date Shares Outstanding | 498.82 | 496.19 | 483.2 | 480.11 | 459.99 | 459.97 |
Total Common Shares Outstanding | 498.82 | 496.19 | 483.2 | 480.11 | 459.99 | 459.97 |
Working Capital | 1,251 | 1,210 | 1,014 | 762.15 | 649.9 | 322.64 |
Book Value Per Share | 5.36 | 5.09 | 4.08 | 3.23 | 2.39 | 1.82 |
Tangible Book Value | 2,546 | 2,415 | 1,884 | 1,461 | 1,022 | 784.62 |
Tangible Book Value Per Share | 5.10 | 4.87 | 3.90 | 3.04 | 2.22 | 1.71 |
Buildings | - | 1,003 | 909.22 | 459.58 | 458.26 | 405.68 |
Machinery | - | 650.21 | 459.5 | 359.41 | 316.06 | 245.82 |
Construction In Progress | - | 80.97 | 69.32 | 308.14 | 18.16 | 24.88 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.